Researchers at Washington
University School of Medicine in St. Louis have found that prostate cancer screening with prostate specific antigen showed
no obvious prostate cancer mortality benefit in a study of 76,000 men over 10 to 13 years. Prostate cancer expert Gerald L. Andriole, Chief, Division of Urologic Surgery and Director, Men's Health Center at Barnes-Jewish Hospital in St. Louis says “The message is that routine mass screening is not the way to go.”
Read more: http://urology.wustl.edu/Physicians.
Read more: http://urology.wustl.edu/Physicians.
